Articles Mentioning Healthcare Stocks

Results 1 - 10 of 435 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Healthcare

Investing | October 09, 2015

Amgen Was Clobbered in September -- Here's Why

Calls for prescription drug reform blast the original biotech blue-chip stock in September. Could Amgen have more downside to come, or is this latest dip an early holiday gift?

Investing | September 24, 2015

Amgen Gets a Step Closer to a Multibillion-Dollar Market

Amgen and Allergan's ABP 215 biosimilar to Avastin posted positive results in phase 3 trials.

Investing | September 04, 2015

PCSK9 Drugs Are Here (and Way Over There)

As the first generation of the cholesterol-lowering drugs hits the market, investors should already be looking at the next-generation products.

Investing | June 11, 2015

3 Things AbbVie Inc.'s Management Wants You to Know

AbbVie's management team had a lot to talk about on their last investor conference call. Here are my three takeaways you need to know when considering the stock for investment.

Investing | April 25, 2015

3 Best Stocks for Investing in Generic Drugs

The generic-drug market is sizzling hot. Here are three investing ideas to catch some of that heat wave.

Investing | April 19, 2015

3 Stocks That Could Double Your Money

These three companies have the potential to double their share price from current levels. Here's why.

Investing | April 05, 2015

Can This Pharma Go From Good to Great?

Will Actavis' $66 billion merger with Allergan catapult this company from good to great? Or could a hidden risk derail this global powerhouse?

Investing | March 09, 2015

Why AbbVie Inc.'s $21 Billion Deal Had To Happen

AbbVie Inc has agreed to pay $21 billion to acquire Pharmacyclics, Inc.

Investing | February 16, 2015

Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?

Pfizer recently acquired Hospira for $17 billion, but it has plenty of fuel left to go after more deals to boost its pipeline and shareholder value.

Investing | February 14, 2015

2 Small Biotech Stocks Dreaming Big in Hepatitis C

Exciting but speculative -- Industry Focus examines two companies making strides in the treatment of hepatitis C.

Results 1 - 10 of 435 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Healthcare